Back to top

Adamis Pharmaceuticals (ADMP) in Focus: Stock Moves 8% Higher

Read MoreHide Full Article

Adamis Pharmaceuticals Corporation (ADMP - Free Report) was a big mover last session, as the company saw its shares rise 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 44.6% in the past one-month time frame.

The company has seen no changes when it comes to estimate revision over the past month, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Adamis Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.  

A better-ranked stock in the Medical – Drugs industry is BioSpecifics Technologies Corp (BSTC - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ADMP going up? Or down? Predict to see what others think: Up or Down

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


 




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


BioSpecifics Technologies Corp (BSTC) - free report >>

Adamis Pharmaceuticals Corporation (ADMP) - free report >>

More from Zacks Tale of the Tape

You May Like